Compounds > pyridoxal phosphate

pyridoxal phosphate and 2',3'-dialdehyde atp

pyridoxal phosphate has been researched along with 2',3'-dialdehyde atp in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's5 (62.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bloom, BR; Brosnan, C; Buell, G; Chessel, I; Liu, J; Sikora, A1
Chessell, IP; Grahames, CB; Humphrey, PP; Michel, AD1
Chessell, IP; Humphrey, PP; Kaur, R; Michel, AD1
Kimura, J; Matsuoka, I; Watano, T1
Adinolfi, E; Baricordi, OR; Chiozzi, P; Di Virgilio, F; Morelli, A; Rizzo, R; Solini, A1
Arcuino, G; Goldman, SA; Li, P; Lin, J; Liu, QS; Nedergaard, M; Peng, WG; Takano, T; Wan, P; Wang, X; Xu, Q1
Zhao, HB1
Alberdi, E; Aparicio, D; Domercq, M; Matute, C; Pampliega, O; Perez-Samartin, A1

Other Studies

8 other study(ies) available for pyridoxal phosphate and 2',3'-dialdehyde atp

ArticleYear
Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism.
    Journal of immunology (Baltimore, Md. : 1950), 1999, Jul-15, Volume: 163, Issue:2

    Topics: Adenosine Triphosphate; Animals; Cell Line; Free Radicals; Macrophage Activation; Macrophages; Mice; Mycobacterium bovis; Mycobacterium tuberculosis; Nitric Oxide; Nitric Oxide Synthase; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Reactive Oxygen Species; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger; Signal Transduction; Suramin

1999
Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes.
    British journal of pharmacology, 1999, Volume: 127, Issue:8

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Cell Line; Enzyme Inhibitors; Humans; Interleukin-1; L-Lactate Dehydrogenase; Lipopolysaccharides; Monocytes; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X7

1999
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
    British journal of pharmacology, 2000, Volume: 130, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Antibodies, Blocking; Benzoxazoles; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Inhibitors; Fluorescent Dyes; Humans; Imidazoles; In Vitro Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Receptors, Purinergic P2X7; Stimulation, Chemical

2000
Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation.
    Japanese journal of pharmacology, 2002, Volume: 88, Issue:4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Benzoxazoles; Cations; Cell Membrane Permeability; Fluorescent Dyes; Mice; Patch-Clamp Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Suramin; Triazines; Tumor Cells, Cultured

2002
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:7

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Diphosphate; Adenosine Triphosphate; Apoptosis; Apyrase; Autocrine Communication; Cell Shape; Cytidine Triphosphate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibroblasts; Fibronectins; Gene Expression Regulation; Humans; Interleukin-6; Membrane Potentials; Paracrine Communication; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Uridine Diphosphate; Uridine Triphosphate

2004
P2X7 receptor inhibition improves recovery after spinal cord injury.
    Nature medicine, 2004, Volume: 10, Issue:8

    Topics: Adenosine Triphosphate; Animals; Apoptosis; Benzoxazines; Disease Models, Animal; Electrophysiology; Female; Immunohistochemistry; In Situ Nick-End Labeling; Luminescent Measurements; Microscopy, Confocal; Neurons; Oxazines; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Spinal Cord Injuries

2004
Connexin26 is responsible for anionic molecule permeability in the cochlea for intercellular signalling and metabolic communications.
    The European journal of neuroscience, 2005, Volume: 21, Issue:7

    Topics: Adenosine Triphosphate; Affinity Labels; Animals; Anions; Anti-Inflammatory Agents; Calcium; Cations; Cell Communication; Cell Count; Cell Membrane Permeability; Cells, Cultured; Cochlea; Connexin 26; Connexins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Dyes; Gap Junctions; Glycyrrhetinic Acid; Guinea Pigs; Intracellular Membranes; Platelet Aggregation Inhibitors; Proadifen; Pyridoxal Phosphate; Spectrometry, Fluorescence; Time Factors

2005
P2X7 receptors mediate ischemic damage to oligodendrocytes.
    Glia, 2010, Apr-15, Volume: 58, Issue:6

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Animals, Newborn; Axons; Calcium; Cell Death; Connexins; Excitatory Amino Acid Antagonists; Glucose; Hypoxia; L-Lactate Dehydrogenase; Microscopy, Electron, Transmission; Nerve Tissue Proteins; Oligodendroglia; Optic Nerve; Optic Neuropathy, Ischemic; Patch-Clamp Techniques; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Reactive Oxygen Species; Receptors, Purinergic P2; Receptors, Purinergic P2X7

2010